Atlantic Union Bankshares Corp Gilead Sciences, Inc. Transaction History

Atlantic Union Bankshares Corp

$1.54 Billion
Q2 2024

A detailed history of Atlantic Union Bankshares Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 108,376 shares of GILD stock, worth $9.55 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

108,376

Previous 92,065 17.72%

Holding current value

$9.55 Million

Previous $6.74 Million 10.26%

% of portfolio

0.48%

Previous 0.59%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$63.15 - $72.88 $1.03 Million - $1.19 Million	16,311 Added 17.72%	108,376 $7.44 Million
Q1 2024 Apr 16, 2024	BUY	$71.58 - $87.29 $414,519 - $505,496	5,791 Added 6.71%	92,065 $6.74 Million
Q4 2023 Jan 19, 2024	BUY	$73.27 - $83.09 $185,080 - $209,885	2,526 Added 3.02%	86,274 $6.99 Million
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $89,689 - $97,852	1,213 Added 1.47%	83,748 $6.28 Million
Q2 2023 Jul 11, 2023	BUY	$76.01 - $86.7 $5.42 Million - $6.19 Million	71,339 Added 637.18%	82,535 $6.36 Million
Q1 2023 May 08, 2023	BUY	$77.31 - $88.08 $437,110 - $498,004	5,654 Added 102.02%	11,196 $928,000
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $63,943 - $80,128	-1,104 Reduced 16.61%	5,542 $329,000
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $87,198 - $98,972	-1,344 Reduced 16.82%	6,646 $482,000
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $43,389 - $46,812	-641 Reduced 7.43%	7,990 $558,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $260,227 - $284,335	-4,100 Reduced 32.2%	8,631 $595,000
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $121,140 - $138,220	-2,019 Reduced 13.69%	12,731 $823,000
Q4 2020 Feb 01, 2021	SELL	$56.65 - $64.55 $59,482 - $67,777	-1,050 Reduced 6.65%	14,750 $860,000
Q3 2020 Oct 16, 2020	BUY	$62.1 - $78.08 $13,972 - $17,568	225 Added 1.44%	15,800 $998,000
Q2 2020 Jul 15, 2020	SELL	$72.34 - $84.0 $9,042 - $10,500	-125 Reduced 0.8%	15,575 $1.2 Million
Q1 2020 Apr 10, 2020	BUY	$62.63 - $80.22 $178,119 - $228,145	2,844 Added 22.12%	15,700 $1.17 Million
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $41,223 - $45,344	-669 Reduced 4.95%	12,856 $835,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $41,881 - $46,230	-670 Reduced 4.72%	13,525 $857,000
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $878,244 - $984,849	14,195 New	14,195 $959,000
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $181,075 - $236,289	-2,991 Closed	0 $0
Q3 2018 Oct 11, 2018	SELL	$71.28 - $78.92 $21,170 - $23,439	-297 Reduced 9.03%	2,991 $231,000
Q2 2018 Jul 12, 2018	BUY	$64.88 - $75.68 $9,018 - $10,519	139 Added 4.41%	3,288 $233,000
Q1 2018 Apr 11, 2018	SELL	$72.84 - $88.8 $11,290 - $13,764	-155 Reduced 4.69%	3,149 $238,000
Q4 2017 Jan 10, 2018	SELL	$71.15 - $83.52 $40,911 - $48,024	-575 Reduced 14.82%	3,304 $236,000
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $279,714 - $331,538	3,879	3,879 $314,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.

Account

Atlantic Union Bankshares Corp Gilead Sciences, Inc. Transaction History